Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
Pharma powerhouse names Cecile Guegan interim finance chief
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Hair care & quick commerce shine
Subscribe To Our Newsletter & Stay Updated
